Systematic review with meta‐analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel-Reference-Cited by-同舟云学术

Systematic review with meta‐analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel

Published:2018-09-04 Issue:8 Volume:48 Page:780-796
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Batchelor Riley¹^ORCID,Kumar Radya¹,Gilmartin‐Thomas Julia F. M.¹²^ORCID,Hopper Ingrid¹^ORCID,Kemp William³^ORCID,Liew Danny¹^ORCID

Affiliation:

1. Department of Epidemiology and Preventive Medicine School of Public Health and Preventive Medicine Monash University Melbourne Australia

2. Research Department of Practice and Policy University College London School of Pharmacy London UK

3. Department of Gastroenterology Alfred Health Melbourne Australia

Funder

National Health and Medical Research Council

Australian Research Council

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.14955

Reference80 articles.

1. Adverse effects of proton pump inhibitor drugs: clues and conclusions

2. Failing the Acid Test

3. IMS Institute for Healthcare Informatics.Medicine Use and Shifting Costs of Healthcare: A Review of the Use of Medicines in the United States in 2013.http://www.imshealth.com/cds/imshealth/Global/Content/Corporate/IMS%20Health%20Institute/Reports/Secure/IIHI_USUse_of_Meds_for_2013.pdf. Accessed 15 November 2017.

4. Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting;Heidelbaugh JJ;Am J Manag Care,2010

5. Inappropriate prescribing of proton pump inhibitors in primary care

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton pump inhibitors and risk of bloodstream infection without an identifiable source: a hospital-based case-control study;Japanese Journal of Infectious Diseases;2024-01-31

2. Long-Term Use of Proton-Pump Inhibitors: Unravelling the Safety Puzzle;Cureus;2024-01-23

3. Association between the Use of Proton Pump Inhibitors and Cardiovascular Diseases: A Nested Case-Control Study Using a National Health Screening Cohort;Biomedicines;2024-01-12

4. Budget Impact of RefluxStopTM as a Treatment for Patients with Refractory Gastro-oesophageal Reflux Disease in the United Kingdom;Journal of Health Economics and Outcomes Research;2024-01-11

5. Budget Impact of RefluxStop™ as a Treatment for Patients with Refractory Gastro-oesophageal Reflux Disease in the United Kingdom;Journal of Health Economics and Outcomes Research;2024-01-11